A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Phase of Trial: Phase II
Latest Information Update: 02 May 2019
Price : $35 *
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Aclaris Therapeutics
- 28 Mar 2018 Status changed from active, no longer recruiting to completed.
- 11 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
- 08 Jan 2018 Results published in the Aclaris Therapeutics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History